AI is changing drug discovery faster than most people expected. Commercial manufacturing is next. The organizations best positioned for that shift are the ones preparing now, not because they’re behind, but because the window to prepare thoughtfully is exactly when...
In the wake of the COVID-19 pandemic and the associated development of a vaccine in record time, the biopharmaceutical industry has seen significant change. Today, we know that faster development is possible, though it is still challenging. That has increased the...
In the last few years, life sciences innovation has jumped by leaps and bounds. Many of the emerging autologous, patient-specific therapies being released are accomplishing things the general public never thought would be possible. These autologous treatments are...
Continuous manufacturing was a game-changer for the ability to deliver life-improving and life-saving biopharmaceutical treatments to patients as quickly as possible. Automation made it possible to make manufacturing significantly more efficient, helping teams to...
Eliminating silos of data into a comprehensive industrial data fabric enables reshaping the data landscape to provide aggregated, contextualized data for digital transformation initiatives for pharmaceutical & biotech manufacturers.
It’s hard to discuss the life sciences today without talking about advanced therapeutics and personalized medicine. We are currently in a period of massive innovation that will reshape the delivery of medicine for decades to come. Where once pharmaceutical companies...
As systems become increasingly interconnected, we talk more and more about the importance of data and, more specifically, the need to get data to the right people, in the right format, at the right time, wherever they may be. This initiative has become even more...
In the life sciences, bringing treatments to market quicker is no longer a bonus. Today, accelerating the treatment development pipeline is an expectation—arguably a core value—of the world’s most respected pharmaceutical companies. The pipeline for the COVID vaccine...
To know where you’re going, you have to know where you are, and operating a life sciences manufacturing facility is no exception. Pharmaceutical processors regularly have to take stock of their technological capacity to keep a finger on the pulse of the four main...
Recently, as cell and gene therapies have begun to emerge in the life sciences manufacturing landscape, an important concept has begun to draw attention: traceability. However, it is important to remember that traceability was critical long before today’s most...
People are more aware than ever of the many amazing ways new treatments can improve their lives. As a result, life sciences companies are under more pressure than ever to safely deliver new, innovative treatments to market to satisfy customer demand. The key to...
In just the last 10 years, biopharmaceutical supply chains have changed dramatically. The single-source manufacturing model is becoming much rarer, making way for multi-enterprise manufacturing collaborations and partnerships to better meet the changing needs of the...
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.